Cynosure (CYNO) PT, Estimates Trimmed at Stifel Despite Solid Results

October 25, 2016 1:08 PM EDT
Get Alerts CYNO Hot Sheet
Price: $44.00 +0.57%

Rating Summary:
    8 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade CYNO Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Stifel analyst Jonathan Block trimmed estimates and his price target on Cynosure (NASDAQ: CYNO) to $58.00 (from $62.00) but maintained a Buy rating following solid results.

Block commented, "Cynosure delivered another solid quarter with revenue and EPS ahead of our estimates. Product revenue upside was across both N.A. and notably, international as O-U.S. traction begins to increase. We believe momentum will continue to build as the international division begins to benefit from the broader launch of SculpSure (and its accompanying recurring PAC), PicoSure's ongoing strength in APAC, and to a lesser extent, MonaLisa Touch (MLT). The N.A. division has benefited from these products for the past 12+ months and revenue is +47% LTM. While the 3Q16 top-line was relatively solid, we believe the q/q draw down in deferred revenue weighed on the perception of the beat a bit, and more importantly, our concerns about the amount of near-term leverage come into play causing us to lower our 2017 EPS estimate from $1.90 to $1.65 despite the top-line relatively unchanged."

For an analyst ratings summary and ratings history on Cynosure click here. For more ratings news on Cynosure click here.

Shares of Cynosure closed at $49.69 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities


Add Your Comment